TY - JOUR
T1 - Divergent approaches in the vaccination of recently arrived migrants to europe
T2 - A survey of national experts from 32 Countries, 2017
AU - ESGITM Working Group on Vaccination in Migrants
AU - Hargreaves, Sally
AU - Nellums, Laura B.
AU - Ravensbergen, Sofanne J.
AU - Friedland, Jon S.
AU - Stienstra, Ymkje
A2 - Zavadska, Dace
N1 - Funding Information:
This research was funded by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) through ESCMID Study Group Research Funding. SH, LBN, and JSF are funded by the Imperial NIHR Biomedical Research Centre, the Imperial College Healthcare Charity, and the Wellcome Trust (Grant number 209993/Z/17/Z). We would like to acknowledge the Gratama Foundation for their contribution. We would like to thank the following participants for their valued input in this project: Alison Crawshaw, Taneli Puumalainen, Ursula Trummer, Geert Top, Rossitza Vatcheva-Dobrevska, Radosveta Filipova, Maria Koliou, Roman Prymula, Asko Jarvinen, Odile Kremp, Ole Wichmann, Zoltan Katz, Istvan Szilard, Cliona Ni Cheallaigh, Lelia Thornton, Susanna Esposito, Dace Zavadska, Pierre Weicherding, Charmaine Gauci, Henrigue Barros, Sonia Dias, Emiliana Costiug, Henrieta Hudečková, Ann Lindstrand, Virginie Masserey, Francesco Maraglino, Helma Ruijs, Nerija Kupreviciene, Mary Ramsay, Vanessa Saliba.
Publisher Copyright:
© 2018, European Centre for Disease Prevention and Control (ECDC). All rights reserved.
PY - 2018/10/11
Y1 - 2018/10/11
N2 - Background: Migrants within the European Union and European Economic Area (EU/EEA) may be underim-munised and lack documentation on previous vaccinations. We investigated approaches to vaccination in recently arrived adult and child migrants, and guideline availability and implementation. Methods: Between March and May 2017, a national vaccination expert from every EU/EEA country and Switzerland completed an electronic questionnaire. We used descriptive analyses to calculate percentages, and framework analysis to synthesise free-text responses. Results: We approached 32 countries (response rate 100%). Although 28 experts reported vaccination guidance at national level, specific guidelines for recently arrived migrants were only available in six countries and not consistently implemented. Twenty-three countries administered vaccinations during on-arrival health checks. Most experts recommended multiple vaccination opportunities be made available: at point of entry (n = 13) or at holding level (reception centres, migrant camps, detention centres) (n = 21). In 30 countries, child migrants without evidence of previous vaccination were re-vaccinated according to the national schedule. Diphtheria-pertussis-tetanus and polio vaccinations were given to migrant children in all countries, measles-mumps-rubella (MMR) in 31 countries, hepatitis B vaccination in 25. Low levels of catch-up vaccination were reported in adult migrants, with only 13 countries offering MMR and 10 countries charging fees. Conclusion: Existing guidance is often not migrant-specific and may not be applied in practice; clarification is needed on which vaccines should be given. Strategies are needed specifically for catch-up vaccination in adult migrants. Vaccinations should be offered in multiple settings, free of charge, with sufficient guidance and training provided to front-line healthcare professionals.
AB - Background: Migrants within the European Union and European Economic Area (EU/EEA) may be underim-munised and lack documentation on previous vaccinations. We investigated approaches to vaccination in recently arrived adult and child migrants, and guideline availability and implementation. Methods: Between March and May 2017, a national vaccination expert from every EU/EEA country and Switzerland completed an electronic questionnaire. We used descriptive analyses to calculate percentages, and framework analysis to synthesise free-text responses. Results: We approached 32 countries (response rate 100%). Although 28 experts reported vaccination guidance at national level, specific guidelines for recently arrived migrants were only available in six countries and not consistently implemented. Twenty-three countries administered vaccinations during on-arrival health checks. Most experts recommended multiple vaccination opportunities be made available: at point of entry (n = 13) or at holding level (reception centres, migrant camps, detention centres) (n = 21). In 30 countries, child migrants without evidence of previous vaccination were re-vaccinated according to the national schedule. Diphtheria-pertussis-tetanus and polio vaccinations were given to migrant children in all countries, measles-mumps-rubella (MMR) in 31 countries, hepatitis B vaccination in 25. Low levels of catch-up vaccination were reported in adult migrants, with only 13 countries offering MMR and 10 countries charging fees. Conclusion: Existing guidance is often not migrant-specific and may not be applied in practice; clarification is needed on which vaccines should be given. Strategies are needed specifically for catch-up vaccination in adult migrants. Vaccinations should be offered in multiple settings, free of charge, with sufficient guidance and training provided to front-line healthcare professionals.
UR - http://www.scopus.com/inward/record.url?scp=85055079361&partnerID=8YFLogxK
U2 - 10.2807/1560-7917.ES.2018.23.41.1700772
DO - 10.2807/1560-7917.ES.2018.23.41.1700772
M3 - Article
C2 - 30326996
AN - SCOPUS:85055079361
SN - 1025-496X
VL - 23
JO - EUROSURVEILLANCE
JF - EUROSURVEILLANCE
IS - 41
M1 - 1700772
ER -